Introduction: Oral mucocele is considered as the most frequent benign minor (accessory) salivary gland lesion, which is brought on by mechanical stress to the gland's excretory duct.The standard therapy is surgical excision, which entails removing the whole tumor together with the related salivary gland. However, surgery may harm the nearby small salivary glands, which could result in the development of additional mucoceles. Steroid injections, cryosurgery, laser therapy, and micro-marsupialization are the examples of alternative therapies. Aim and objective: The goal of the current study was to assess the effectiveness of intralesional injections of betamethasone as a nonsurgical treatment option for oral mucoceles. Materials and Methods: A total of twenty individuals (10 males and 10 females, aged 10 to 30) with clinically diagnosed oral mucoceles, received an intralesional dose of one milliliter of betamethasone. After7,14, and 21 days, each patient underwent an examination to determine how the lesion responded to treatment and subsequently the second, third, and fourth injections. Treatment was stopped if the lesion cleared up after one or two injections. Results: Of the the 20 patients, 4patients had complete regression of the lesion, whereas 16 patients had a reduction in the size of the lesion. The overall p value was